Holen Sie sich die Stockscreener-App
1.92
3.03%
-0.06
Handel nachbörslich:
1.95
0.03
+1.56%
Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten
Director boosts stake in Serina Therapeutics (SER) with 20K-share buy - Stock Titan
Serina Therapeutics Inc (SER) Q1 2026 Earnings: EPS Miss Amid Continued Development ProgressFinancial Summary - Newser
Serina Therapeutics Q1 2026 Earnings: EPS Misses Estimates as Stock Climbs Despite LossGAAP Earnings Report - Newser
Serina Therapeutics Inc. (SER) Recovers 4.93% as Stock Approaches Key Resistance at $2.08Volume Spike Alerts - Newser
Serina Therapeutics Inc. (SER) Gains Nearly 5% as Stock Approaches Key ResistanceTop Analyst Buy Signals - Newser
Director at Serina Therapeutics (SER) makes open-market buy of 12,183 shares - Stock Titan
16.45M Serina shares registered for resale (NYSE: SER) - Stock Titan
Serina Therapeutics : Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi - marketscreener.com
SER Stock Price, Quote & Chart | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
Serina Therapeutics (SER) Gets a Buy from JonesTrading - The Globe and Mail
Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks - The Globe and Mail
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Serina Therapeutics 1Q Loss/Shr 58c >SER - Moomoo
Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times
Parkinson's drug trial moves ahead as Serina adds $21.2M funding - Stock Titan
Serina Therapeutics (NYSE: SER) raises $21.2M and advances SER-252 trial - Stock Titan
Serina Therapeutics (NYSE: SER) posts Q1 loss and raises $21.2M PIPE amid cash risk - Stock Titan
Serina Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
SER Technical Analysis | Trend, Signals & Chart Patterns | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
MSN Money - MSN
TradingKey - TradingKey
What Serina Therapeutics (SER) is doing to stay ahead (Slight Loss) 2026-05-08Social Trade Signals - newser.com
How Serina Therapeutics (SER) responds when competition intensifies (Volatility Increases) 2026-05-08Community Buy Alerts - newser.com
The recurring revenue story behind Serina Therapeutics (SER) | Q4 2025: EPS Exceeds ExpectationsPut/Call Ratio - newser.com
Sio Capital (SER) reports 1,000,000 shares, 6.71% stake in Serina Therapeutics - Stock Titan
Serina Therapeutics (SER) Stock: Is It a Strong Investment Pick | Q4 2025: Earnings Beat EstimatesTrending Entry Points - newser.com
Chart Pattern Insight | Serina Therapeutics notches 33% EPS beat, tops loss estimatesPost Earnings - newser.com
Serina Therapeutics (NYSE: SER) seeks share increase and equity plan changes in 2026 proxy - Stock Titan
Serina Therapeutics Updates Executive Leadership and Governance Structure - The Globe and Mail
0.98%
0.12%
Kapitalisierung:
|
Volumen (24h):